导航切换
Journal of Integrative Agriculture
JIA Home
About JIA
Description
Video introduction
Editor-in-chief
Editorial board
Guideline of JIA editorial board
Editorial board
Youth Editorial Board
For authors
Instruction for authors
Title page
Copyright agreement
Templates
Endnote
Subscription
Contact
Journals
Publication Years
Keywords
Search within results
(((CHEN Zheng-li[Author]) AND 1[Journal]) AND year[Order])
AND
OR
NOT
Title
Author
Institution
Keyword
Abstract
PACS
DOI
Please wait a minute...
For Selected:
Download Citations
EndNote
Ris
BibTeX
Toggle Thumbnails
Select
Alphaherpesvirus-vectored vaccines against animal diseases: Current progress
HU Yang, WANG Ming-shu, CHENG An-chun, JIA Ren-yong, YANG Qiao, WU Ying, LIU Ma-feng, ZHAO Xin-xin, ZHU De-kang, CHEN Shun, ZHANG Sha-qiu, WANG Yin, GAO Qun, OU Xu-min, MAO Sai, WEN Xing-jian, XU Zhi-wen, CHEN Zheng-li, ZHU Ling, LUO Qi-hui, TIAN Bin, PAN Lei-chang, Mujeeb Ur REHMAN, LIU Yun-ya, YU Yan-ling, ZHANG Ling, CHEN Xiao-yue
2020, 19 (
8
): 1928-1940. DOI:
10.1016/S2095-3119(20)63175-6
Abstract
(
242
)
PDF in ScienceDirect
Recombinant virus-vectored vaccines are novel agents that can effectively activate specific and nonspecific immunity, are multivalent and multieffective, and have high safety ratings. Animal alphaherpesviruses have a large genome, contain multiple nonessential regions that do not affect viral replication and are capable of accepting the insertion of an exogenous gene and expressing the antigen protein. Furthermore, animal alphaherpesviruses have a wide host spectrum, can replicate in the host and continuously stimulate the animal to produce immunity to the corresponding pathogen, thus making them ideal carriers for recombinant virus-vectored vaccines. With the development of gene-editing technology, recombinant viruses capable of expressing foreign genes can be constructed by various methods. Currently, studies on recombinant virus-vectored vaccines constructed based on animal alphaherpesviruses have involved poultry, pigs, cattle, sheep, and companion animals. Studies have shown that the construction of recombinant animal alphaherpesviruses enables the acquisition of immunity to multiple diseases. This article mainly summarizes the current progress on animal alphaherpesvirus-vectored vaccines, aiming to provide reference for the development of new animal alphaherpesvirus-vectored vaccines.
Reference
|
Related Articles
|
Metrics
Select
The Effect of Glycyl-Glutamine Dipeptide Concentration on Enzyme Activity,Cell Proliferation and Apoptosis of Jejunal Tissues from Weaned Piglets
WANG Hui, JIA Gang, CHEN Zheng-li, HUANG Lan, WU Cai-mei, WANG Kang-ning
2011, 10 (
7
): 1088-1095. DOI:
10.1016/S1671-2927(11)60098-9
Abstract
(
1645
)
PDF in ScienceDirect
An experiment was conducted in a singly factorial design to study the effect of glycyl-glutamine dipeptide on enzymeactivity, cell proliferation and apoptosis of jejunal tissues from weaned piglets at different glycyl-glutamine concentrationlevels of 2, 4, 10, 20, and 30 mmol L-1, respectively. The glutaminase activity, diamine oxidase (DAO) activity, cellpeoliferation, apoptosis, and perotein metabolism were measured by the tissue culture method
in vitro
using jejunaltissues. The immunohistochemical method was used to study the cell proliferation and apoptosis of jejunal tissues. Theresults showed that compared to the blank control, the percentage and MOD value of BrdU-positicve cells incubated withglycyl-glutamine dipeptide solution were significantly (
P
<0.05) increased. Accordingly, the percentage and MOD valueof caspase-3-positive cells from tissue incubated with glycyl-glutamine dipeptide were notably lower (
P
<0.05) than thatfrom the control treatment. The glycyl-glutamine dipeptide increased the glutaminase activity, DAO activity and proteincontent of jejunal tissues, as the dipeptide concentration was on the rise (
P
<0.05). These results indicated that glycylglutaminedipeptide affected the jejunum development and adaptation of weaned piglets, and the function might befulfilled by enhancing the glutamine-related enzyme activity, thereby increasing the consumption of glutamine, and thenimproving the jejunal cell proliferation and suppressing cell apoptosis. The effects of glycyl-glutamine dipeptide relied ina dose-dependent manner, and the maximum effect was achieved at 20-30 mmol L-1 glycyl-glutamine dipeptide.
Reference
|
Related Articles
|
Metrics